Oldip HCT Tablet 10/40/12.5 mg

Adult dose

This medication is taken once daily as one tablet with or without food. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5 mg: Administered to patients whose blood pressure is inadequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/20 mg. - 5/40/12.5 mg: Administered to patients whose blood pressure is inadequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/40 mg.

Child dose

Safety and efficacy for pediatric patients under 18 years have not been established, so the use of this medication is not recommended.

This medication may cause severe harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergy to this medication or its components, specific heart, kidney, or liver diseases, pregnant or breastfeeding women, and some patients with electrolyte abnormalities or shock should not take this medication. Patients with reduced blood volume, impaired kidney function, liver disease, or specific heart valve diseases should use this medication with caution and closely observe their condition while on treatment. This medication can lower blood pressure, thus symptoms of hypotension may occur. In such cases, the patient should be laid down and, if necessary, administered fluids. This medication may affect kidney function; therefore, patients with impaired kidney function should have their kidney function and electrolyte levels regularly checked both before and during use. This medication may interact with certain drugs, so it is essential to consult a doctor or pharmacist if other medications are being taken. This medication can also be used in elderly patients, but they may respond more sensitively, so starting with a low dose is recommended. In case of overdose, symptoms such as hypotension or palpitations may occur, so it is vital to adhere to the prescribed dosage and immediately inform healthcare professionals of any unusual symptoms. This medication should be stored in a place away from direct sunlight and moisture, out of the reach of children, and transferring it to another container should be avoided. Pregnant or breastfeeding women are advised not to take this medication, and if necessary, it should be replaced with other safe medications. Use of this medication in children under 18 years has not been established for safety and efficacy, hence its use is not recommended. Dizziness or drowsiness may occur while taking this medication, so caution is needed when driving or operating machinery. If any unusual skin changes, difficulty breathing, severe rash, or other symptoms appear during treatment, discontinue use immediately and consult healthcare professionals.

Serious side effects

Hives, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, cough with fever associated respiratory distress, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infections
• nasopharyngitis
• urinary tract infections
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius to ensure the medication's effectiveness and safety.

Appearance

Round film-coated tablets with a reddish-gray color

Package unit

28 tablets (14 tablets/PTPX2)/carton